Suppr超能文献

大胆的论述——不:大麻素不应用于急性术后疼痛管理。

Daring discourse - no: cannabinoids should not be used for acute postoperative pain management.

机构信息

Department of Anesthesiology, University of Southern California Keck School of Medicine, Los Angeles, California, USA.

Anesthesiology and Perioperative Care Service, VA Palo Alto Health Care System, Palo Alto, California, USA

出版信息

Reg Anesth Pain Med. 2020 Jul;45(7):520-523. doi: 10.1136/rapm-2020-101475. Epub 2020 May 28.

Abstract

As anesthesiologists and acute pain medicine specialists, we will care for patients in the perioperative period who use cannabinoids for chronic pain and/or marijuana recreationally. We will have to address difficult questions from patients regarding the potential applications for cannabinoids in acute pain management. While we must remain compassionate and understand our patients' desire to find relief from suffering using available non-opioid medications, we are ethically bound to do no harm and provide them with treatment options supported by the best available evidence. Today, we cannot support cannabinoids in the management of acute postoperative pain.

摘要

作为麻醉师和急性疼痛医学专家,我们将在围手术期照顾使用大麻素治疗慢性疼痛和/或消遣性使用大麻的患者。我们将不得不回答患者关于大麻素在急性疼痛管理中潜在应用的难题。虽然我们必须保持同情心并理解患者使用现有非阿片类药物减轻痛苦的愿望,但我们有道德义务不造成伤害,并为他们提供最佳现有证据支持的治疗选择。今天,我们不能支持大麻素治疗急性术后疼痛。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验